X
Please Wait
Applying Filters...
01 DR REDDYS (2)
01 TABLET, DELAYED RELEASE;ORAL (2)
01 RX (2)
01 NAPROXEN AND ESOMEPRAZOLE MAGNESIUM (2)
01 No (2)
19
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is ESOMEPRAZOLE MAGNESIUM; NAPROXEN, with a corresponding application number 204206.
Regulatory Information RX
With a dosage strength EQ 20MG BASE;375MG
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2020-02-18
Therapeutic Equivalence (TE) Code AB
18
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is ESOMEPRAZOLE MAGNESIUM; NAPROXEN, with a corresponding application number 204206.
Regulatory Information RX
With a dosage strength EQ 20MG BASE;500MG
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2020-02-18
Therapeutic Equivalence (TE) Code AB
Market Place
KEY PRODUCTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
